José Manuel Méndez-Arriaga (José M Mendez-Arriaga)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Trypanosoma Cruzi

Breast Cancer Cells

Top Venues

Biomedical materials (Bristol, England)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Michael Aondona Iorhemba, Javier Álvarez Conde, Diana Díaz-García, José Manuel Méndez-Arriaga, Victoria García-Almodóvar, Karina Ovejero-Paredes, Sulaiman Ola Idris, Gideon Adamu Shallangwa, Ibrahim Abdulkadir, Sanjiv Prashar, Marco Filice, Santiago Gómez-Ruiz
Vanadocene-functionalized mesoporous silica nanoparticles: platforms for the development of theranostic materials against breast cancer. Biomedical materials (Bristol, England) 19 (3) (2024)
Michael Aondona Iorhemba, Javier Álvarez Conde, Diana Díaz-García, José Manuel Méndez-Arriaga, Victoria García-Almodóvar, Karina Ovejero-Paredes, Sulaiman Ola Idris, Gideon Adamu Shallangwa, Ibrahim Abdulkadir, Sanjiv Prashar, Marco Filice, Santiago Gómez-Ruiz
Vanadocene-functionalized mesoporous silica nanoparticles: platforms for the development of theranostic materials against breast cancer. Biomedical materials (Bristol, England) 19 (3) (2024)
Michael Aondona Iorhemba, Javier Álvarez-Conde, Diana Díaz-García, José Manuel Méndez-Arriaga, Victoria García-Almodóvar, Karina Ovejero-Paredes, Sulaiman Ola Idris, Gideon Adamu Shallangwa, Ibrahim Abdulkadir, Sanjiv Prashar, Marco Filice, Santiago Gómez-Ruiz
Vanadocene-functionalized mesoporous silica nanoparticles: platforms for the development of theranostic materials against breast cancer. Biomedical materials (Bristol, England) (2024)
Álvaro Martín-Montes, Sandra Jimenez-Falcao, Santiago Gómez-Ruiz, Clotilde Marín, José Manuel Méndez-Arriaga
First-Row Transition 7-Oxo-5-phenyl-1,2,4-triazolo[1,5-a]pyrimidine Metal Complexes: Antiparasitic Activity and Release Studies. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)